Fossil Group Inc. buy Traumtanz
Start price
28.08.25
/
50%
€2.58
Target price
28.09.25
-
Performance (%)
3.53%
End price
02.09.25
€2.67
Summary
This prediction ended on 02.09.25 with a price of €2.67. With a performance of 3.53%, the BUY prediction by Traumtanz for Fossil Group Inc. closed with a slight gain. Traumtanz has a follow-up prediction for Fossil Group Inc., but this time predicts that Fossil Group Inc. is a Sell. Traumtanz has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Fossil Group Inc. | -9.148% |
iShares Core DAX® | 0.378% |
iShares Nasdaq 100 | -0.117% |
iShares Nikkei 225® | -0.806% |
iShares S&P 500 | 0.059% |
According to Traumtanz what are the pros and cons of Fossil Group Inc. for the foreseeable future?
Pros
Cons
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
Low dividend yield expected
negative Cash Flow expected
Bad rating
Little Investments for future growth
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
Below average Management
Bad culture
Little innovation
Few uniques
Dependend from some customers or products
Growths slower than the competition
Sustainability is little important
high free float
Higher risks for its business
Below average Marketposition
Significant cyclical dependencies
Little known brand
Business model of the past or high risk
Comments by Traumtanz for this prediction
In the thread Trading Fossil Group Inc.
Buy beendet
Current prediction by Traumtanz for Fossil Group Inc.
Fossil Group Inc.
Start price
Target price
Perf. (%)
€2.32
27.09.25
27.09.25
€1.00
-
26.09.25
26.09.25
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Stopped prediction by Traumtanz for Fossil Group Inc.
Fossil Group Inc.
Start price
Target price
Perf. (%)
€2.77
05.09.25
05.09.25
€3.00
05.09.26
05.09.26
-16.04%
27.09.25
27.09.25
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group